24.01.2014 Views

CDC Article-US Medical Eligibility Criteria for Contraceptive Use, 2010

CDC Article-US Medical Eligibility Criteria for Contraceptive Use, 2010

CDC Article-US Medical Eligibility Criteria for Contraceptive Use, 2010

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

30 MMWR June 18, <strong>2010</strong><br />

433. el-Raghy L, Black DJ, Osman F, Orme ML, Fathalla M. <strong>Contraceptive</strong><br />

steroid concentrations in women with early active schistosomiasis: lack<br />

of effect of antischistosomal drugs. Contraception 1986;33:373–7.<br />

434. Gad-el-Mawla N, Abdallah A. Liver function in bilharzial females<br />

receiving contraceptive pills. Acta Hepato 1969;16:308–10.<br />

435. Gad-el-Mawla N, el-Roubi O, Sabet S, Abdallah A. Plasma lipids and<br />

lipoproteins in bilharzial females during oral contraceptive therapy. J<br />

Egypt Med Assoc 1972;55:137–47.<br />

436. Shaaban MM, Hammad WA, Falthalla MF, et al. Effects of oral contraception<br />

on liver function tests and serum proteins in women with<br />

active schistosomiasis. Contraception 1982;26:75–82.<br />

437. Shaaban MM, Ghaneimah SA, Mohamed MA, Abdel-Chani S, Mostafa<br />

SA. Effective of oral contraception on serum bile acid. Int J Gynaecol<br />

Obstet 1984;22:111–5.<br />

438. Sy FS, Osteria TS, Opiniano V, Gler S. Effect of oral contraceptive on<br />

liver function tests of women with schistosomiasis in the Philippines.<br />

Contraception 1986;34:283–94.<br />

439. Tagy AH, Saker ME, Moussa AA, Kolgah A. The effect of low-dose<br />

combined oral contraceptive pills versus injectable contracetpive (Depot<br />

Provera) on liver function tests of women with compensated bilharzial<br />

liver fibrosis. Contraception 2001;64:173–6.<br />

440. Beck P, Wells SA. Comparison of the mechanisms underlying carbohydrate<br />

intolerance in subclinical diabetic women during pregnancy<br />

and during post-partum oral contraceptive steroid treatment. J Clin<br />

Endocrinol Metab 1969;29:807–18.<br />

441. Kjos SL, Peters RK, Xiang A, et al. Contraception and the risk of type<br />

2 diabetes mellitus in Latina women with prior gestational diabetes<br />

mellitus. JAMA 1998;280:533–8.<br />

442. Kung AW, Ma JT, Wong VC, et al. Glucose and lipid metabolism<br />

with triphasic oral contraceptives in women with history of gestational<br />

diabetes. Contraception 1987;35:257–69.<br />

443. Radberg T, Gustafson A, Skryten A, Karlsson K. Metabolic studies in<br />

gestational diabetic women during contraceptive treatment: effects on<br />

glucose tolerance and fatty acid composition of serum lipids. Gynecol<br />

Obstet Invest 1982;13:17–29.<br />

444. Skouby SO, Molsted-Pedersen L, Kuhl C. Low dosage oral contraception<br />

in women with previous gestational diabetes. Obstet Gynecol<br />

1982;59:325–8.<br />

445. Skouby SO, Andersen O, Kuhl C. Oral contraceptives and insulin<br />

receptor binding in normal women and those with previous gestational<br />

diabetes. Am J Obstet Gynecol 1986;155:802–7.<br />

446. Skouby SO, Andersen O, Saurbrey N, Kuhl C. Oral contraception<br />

and insulin sensitivity: in vivo assessment in normal women and<br />

women with previous gestational diabetes. J Clin Endocrinol Metab<br />

1987;64:519–23.<br />

447. Xiang AH, Kawakubo M, Kjos SL, Buchanan TA. Long-acting<br />

injectable progestin contraception and risk of type 2 diabetes in<br />

Latino women with prior gestational diabetes mellitus. Diabetes Care<br />

2006;29:613–7.<br />

448. Kjos SL, Shoupe D, Douyan S, et al. Effect of low-dose oral contraceptives<br />

on carbohydrate and lipid metabolism in women with recent<br />

gestational diabetes: results of a controlled, randomized, prospective<br />

study. Am J Obstet Gynecol 1990;163:1822–7.<br />

449. Radberg T, Gustafson A, Skryten A, Karlsson K. Metabolic studies<br />

in women with previous gestational diabetes during contraceptive<br />

treatment: effects on serum lipids and high density lipoproteins. Acta<br />

Endocrinol (Copenh) 1982;101:134–9.<br />

450. Skouby SO, Kuhl C, Molsted-Pedersen L, Petersen K, Christensen<br />

MS. Triphasic oral contraception: metabolic effects in normal women<br />

and those with previous gestational diabetes. Am J Obstet Gynecol<br />

1985;153:495–500.<br />

451. Beck P, Arnett DM, Alsever RN, Eaton RP. Effect of contraceptive steroids<br />

on arginine-stimulated glucagon and insulin secretion in women.<br />

ll. Carbohydrate and lipid phsiology in insulin-dependent diabetics.<br />

Metabolism 1976;25:23–31.<br />

452. Diab KM, Zaki MM. Contraception in diabetic women: comparative<br />

metabolic study of norplant, depot medroxyprogesterone acetate,<br />

low dose oral contraceptive pill and CuT380A. J Obstet Gynecol Res<br />

2000;26:17–26.<br />

453. Garg SK, Chase P, Marshall G, et al. Oral contraceptives and renal and<br />

retinal complications in young women with insulin-dependent diabetes<br />

mellitus. JAMA 1994;271:1099–102.<br />

454. Grigoryan OR, Grodnitskaya EE, Andreeva EN, et al. Contraception<br />

in perimenopausal women with diabetes mellitus. Gynecol Endocrinol<br />

2006;22:198–206.<br />

455. Margolis KL, Adami H-O, Luo J, Ye W, Weiderpass E. A prospective<br />

study of oral contraceptive use and risk of myocardial infarction among<br />

Swedish women. Fertil Steril 2007;88:310–6.<br />

456. Petersen KR, Skouby SO, Sidelmann J, Jespersen J. Assessment of<br />

endothelial function during oral contraception on women with insulindependent<br />

diabetes mellitus. Metabolism 1994;43:1379–83.<br />

457. Petersen KR, Skouby SO, Jespersen J. Balance of coagulation activity<br />

with fibrinolysis during use of oral contraceptives in women with<br />

insulin-dependent diabetes millitus. Int J Fertil 1995;40:105–11.<br />

458. Radberg T, Gustafson A, Skryten A, Karlsson k. Oral contraception<br />

in diabetic women. A cross-over study on seum and high density<br />

lipoprotein (HDL) lipids and diabetes control during progestogen<br />

and combined estrogen/progestogen contraception. Horm Metab Res<br />

1982;14:61–5.<br />

459. Skouby SO, Jensen BM, Kuhl C, et al. Hormonal contraception in<br />

diabetic women: acceptability and influence on diabetes control and<br />

ovarian function of a nonalkylated estrogen/progestogen compound.<br />

Contraception 1985;32:23–31.<br />

460. Skouby SO, Molsted-Petersen L, Kuhl C, Bennet P. Oral contraceptives<br />

in diabetic womne: metabolic effects of four compounds with different<br />

estrogen/progestogen profiles. Fertil Steril 1986;46:858–64.<br />

461. Bitton A, Peppercorn MA, Antonioli DA, et al. Clinical, biological,<br />

and histologic parameters as predictors of relapse in ulcerative colitis.<br />

Gastroenterology 2001;120:13–20.<br />

462. Cosnes J, Carbonnel F, Carrat F, Beaugerie L, Gendre JP. Oral contraceptive<br />

use and the clinical course of Crohn’s disease: a prospective<br />

cohort study. Gut 1999;45:218–22.<br />

463. Sutherland LR, Ramcharan S, Bryant H, Fick G. Effect of oral contraceptive<br />

use on reoperation following surgery <strong>for</strong> Crohn’s disease. Dig<br />

Dis Sci 1992;37:1377–82.<br />

464. Timmer A, Sutherland LR, Martin F. Oral contraceptive use and<br />

smoking are risk factors <strong>for</strong> relapse in Crohn’s disease. The Canadian<br />

Mesalamine <strong>for</strong> Remission of Crohn’s Disease Study Group.<br />

Gastroenterology 1998;114:1143–50.<br />

465. Wright JP. Factors influencing first relapse in patients with Crohn’s<br />

disease. J Clin Gastroenterol 1992;15:12–6.<br />

466. Grimmer SF, Back DJ, Orme ML, et al. The bioavailability of<br />

ethinyloestradiol and levonorgestrel in patients with an ileostomy.<br />

Contraception 1986;33:51–9.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!